Cargando…
2023 Vascular Research Initiatives Conference: Structural and Immune Cells in Vascular Disease
The 2023 Vascular Research Initiatives Conference (VRIC) was held in Boston, Massachusetts, and coincided with the first day of Vascular Discovery 2023, hosted by the American Heart Association. VRIC attracts vascular clinicians, surgeon-scientists, and basic science researchers to a common arena to...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10463243/ https://www.ncbi.nlm.nih.gov/pubmed/37649474 http://dx.doi.org/10.1016/j.jvssci.2023.100117 |
_version_ | 1785098186539401216 |
---|---|
author | Thaxton, Carly Gallagher, Katherine Dardik, Alan |
author_facet | Thaxton, Carly Gallagher, Katherine Dardik, Alan |
author_sort | Thaxton, Carly |
collection | PubMed |
description | The 2023 Vascular Research Initiatives Conference (VRIC) was held in Boston, Massachusetts, and coincided with the first day of Vascular Discovery 2023, hosted by the American Heart Association. VRIC attracts vascular clinicians, surgeon-scientists, and basic science researchers to a common arena to facilitate the exchange of basic and translational science to stimulate and inspire participants to study and find solutions to vascular conditions. The theme of the conference this year was “Structural and Immune Cells in Vascular Disease.” Abstract sessions focused on venous disease, vascular regeneration, stem cells and wound healing, aortopathies, and the role of the immune system in atherosclerosis. A moderated translational science panel included talks from Dr Chiara Giannarelli and Dr Bhama Ramkhelawon. Recipients of Society for Vascular Surgery partner grants and National Institutes of Health K08 awardees presented their progress reports, and the Resident Research and VRIC Trainee Awardees were acknowledged. The Alexander W. Clowes Distinguished Lecture, entitled “Co-stimulatory Immune Checkpoints in Atherosclerosis: Novel Immunotherapeutic Targets to Combat Atherosclerotic Cardiovascular Disease” was given by Dr Ester Lutgens. VRIC continues to foster interdisciplinary collaborations across the translational field of vascular disease. |
format | Online Article Text |
id | pubmed-10463243 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-104632432023-08-30 2023 Vascular Research Initiatives Conference: Structural and Immune Cells in Vascular Disease Thaxton, Carly Gallagher, Katherine Dardik, Alan JVS Vasc Sci Article The 2023 Vascular Research Initiatives Conference (VRIC) was held in Boston, Massachusetts, and coincided with the first day of Vascular Discovery 2023, hosted by the American Heart Association. VRIC attracts vascular clinicians, surgeon-scientists, and basic science researchers to a common arena to facilitate the exchange of basic and translational science to stimulate and inspire participants to study and find solutions to vascular conditions. The theme of the conference this year was “Structural and Immune Cells in Vascular Disease.” Abstract sessions focused on venous disease, vascular regeneration, stem cells and wound healing, aortopathies, and the role of the immune system in atherosclerosis. A moderated translational science panel included talks from Dr Chiara Giannarelli and Dr Bhama Ramkhelawon. Recipients of Society for Vascular Surgery partner grants and National Institutes of Health K08 awardees presented their progress reports, and the Resident Research and VRIC Trainee Awardees were acknowledged. The Alexander W. Clowes Distinguished Lecture, entitled “Co-stimulatory Immune Checkpoints in Atherosclerosis: Novel Immunotherapeutic Targets to Combat Atherosclerotic Cardiovascular Disease” was given by Dr Ester Lutgens. VRIC continues to foster interdisciplinary collaborations across the translational field of vascular disease. Elsevier 2023-07-10 /pmc/articles/PMC10463243/ /pubmed/37649474 http://dx.doi.org/10.1016/j.jvssci.2023.100117 Text en © 2023 by the Society for Vascular Surgery. Published by Elsevier Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Article Thaxton, Carly Gallagher, Katherine Dardik, Alan 2023 Vascular Research Initiatives Conference: Structural and Immune Cells in Vascular Disease |
title | 2023 Vascular Research Initiatives Conference: Structural and Immune Cells in Vascular Disease |
title_full | 2023 Vascular Research Initiatives Conference: Structural and Immune Cells in Vascular Disease |
title_fullStr | 2023 Vascular Research Initiatives Conference: Structural and Immune Cells in Vascular Disease |
title_full_unstemmed | 2023 Vascular Research Initiatives Conference: Structural and Immune Cells in Vascular Disease |
title_short | 2023 Vascular Research Initiatives Conference: Structural and Immune Cells in Vascular Disease |
title_sort | 2023 vascular research initiatives conference: structural and immune cells in vascular disease |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10463243/ https://www.ncbi.nlm.nih.gov/pubmed/37649474 http://dx.doi.org/10.1016/j.jvssci.2023.100117 |
work_keys_str_mv | AT thaxtoncarly 2023vascularresearchinitiativesconferencestructuralandimmunecellsinvasculardisease AT gallagherkatherine 2023vascularresearchinitiativesconferencestructuralandimmunecellsinvasculardisease AT dardikalan 2023vascularresearchinitiativesconferencestructuralandimmunecellsinvasculardisease |